SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 135 | 2 | 142 | +9 |
| Shares | 44.7M | 690.2K | 45.1M | +1.02M (+2.3%) |
| Value | $3.69B | $56.9M | $2.86B | −$769.7M (−21.2%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 367,949 | $23.3M | 0.03% |
| Fiera Capital Corp | 336,102 | $21.3M | 0.05% |
| Caas Capital Management LP | 112,643 | $7.15M | 0.54% |
| CastleArk Alternatives, LLC | 89,086 | $5.65M | 0.22% |
| Millennium Management LLC | 45,757 | $2.90M | 0.00% |
| Natixis | 33,400 | $2.12M | 0.01% |
| International Biotechnology Trust PLC | 25,000 | $1.58M | 0.39% |
| Marshall Wace, LLP | 20,893 | $1.32M | 0.01% |
| Jane Street Group, LLC | 20,866 | $1.32M | 0.00% |
| PDT Partners, LLC | 8,604 | $546.0K | 0.04% |
| Envestnet Asset Management Inc | 7,928 | $503.0K | 0.00% |
| Qube Research & Technologies Ltd | 5,284 | $335.0K | 0.00% |
| Oppenheimer Asset Management Inc. | 4,945 | $314.0K | 0.00% |
| Twinbeech Capital LP | 4,179 | $265.0K | 0.02% |
| IFP Advisors, Inc | 981 | $65.0K | 0.00% |
| Point72 Hong Kong Ltd | 522 | $33.0K | 0.00% |
| First Horizon Advisors, Inc. | 237 | $14.0K | 0.00% |
| Signaturefd, LLC | 11 | $1.00K | 0.00% |
| Red Tortoise LLC | 49 | $1.00K | 0.00% |
| Bell Investment Advisors, Inc | 6 | $0 | 0.00% |
Sold out (11)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Cormorant Asset Management, LP | 15,000 | $1.24M |
| AlphaCrest Capital Management LLC | 6,300 | $519.0K |
| Blueshift Asset Management, LLC | 5,882 | $485.0K |
| Dark Forest Capital Management LP | 3,793 | $313.0K |
| Raymond James & Associates | 3,110 | $256.0K |
| XTX Topco Ltd | 2,994 | $247.0K |
| Boothbay Fund Management, LLC | 2,799 | $231.0K |
| Los Angeles Capital Management LLC | 2,515 | $207.0K |
| FORA Capital, LLC | 1,546 | $127.0K |
| Captrust Financial Advisors | 126 | $10.0K |
| Federated Hermes, Inc. | 9 | $1.00K |
Not filed for Q3 2021 yet (2)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 636,236 | $52.4M |
| CWM, LLC | 53,948 | $4.45M |